India CDMOs Seek To Counter China With New Industry Body, See Europe As Ally

US Tariff Plan Throws Spanner In The Works

Indian CDMOs could consider collaborating with allies in Europe amid a focused effort via a new industry body to counter existing challenges like China’s manufacturing, regulatory and policy advantages and a shortage of funding and talent in the country even as talk of US tariffs throws a new spoke in the wheel

CRDMO Panel at BioAsia 2025
L to R: Vikash Agarwalla, MD & Partner, BCG; Peter Bains, CEO Designate, Syngene; Manni Kantipudi, CEO, Aragen Lifesciences; Nandini Piramal, Chairperson, Piramal Pharma; Guilano Perfetti, MD & CEO, Jubilant Biosys; Krishna Kanumuri, MD & CEO, Sai Lifesciences; Akhil Ravi, CEO, Aurigene Pharma; Srivari Chandrashekhar, former director BCT (Source -Citeline)

More from India

More from Manufacturing